Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas” or the “Company”) is pleased to announce that it is now preparing to commence human trials to test its lead cannabis product
Read more
Veritas Confirms Readiness for Human Trials of CTL-X for Pain; Projected to Start Early Next Month
